CFGS
HRTX icon

Concourse Financial Group Securities’s Heron Therapeutics HRTX Stock Holding History

Concourse Financial Group Securities’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,280
Closed -$2.09K – 934
2024
Q4 		$2.09K Hold
1,280
– – ﹤0.01% 2011
2024
Q3 		$2.55K Sell
1,280
-300
-19% -$716 ﹤0.01% 1963
2024
Q2 		$5.53K Hold
1,580
– – ﹤0.01% 1845
2024
Q1 		$4.38K Hold
1,580
– – ﹤0.01% 1911
2023
Q4 		$2.69K Hold
1,580
– – ﹤0.01% 1972
2023
Q3 		$1.63K Sell
1,580
-25
-2% -$36 ﹤0.01% 2030
2023
Q2 		$1.86K Hold
1,605
– – ﹤0.01% 2030
2023
Q1 		$2.42K Sell
1,605
-1,916
-54% -$4.8K ﹤0.01% 2022
2022
Q4 		$8.8K Buy
3,521
+554
+19% +$1.78K ﹤0.01% 1698
2022
Q3 		$13K Buy
2,967
+2,549
+610% +$9.97K ﹤0.01% 1417
2022
Q2 		$1K Sell
418
-913
-69% -$3.67K ﹤0.01% 2106
2022
Q1 		$8K Hold
1,331
– – ﹤0.01% 1750
2021
Q4 		$12K Buy
1,331
+259
+24% +$2.64K ﹤0.01% 1806
2021
Q3 		$11K Buy
1,072
+195
+22% +$2.37K ﹤0.01% 1861
2021
Q2 		$14K Hold
877
– – ﹤0.01% 1756
2021
Q1 		$14K Hold
877
– – ﹤0.01% 1666
2020
Q4 		$19K Buy
877
+107
+14% +$1.86K ﹤0.01% 1475
2020
Q3 		$11K Buy
770
+41
+6% +$640 ﹤0.01% 1541
2020
Q2 		$11K Buy
729
+429
+143% +$7.05K ﹤0.01% 1465
2020
Q1 		$4K Hold
300
– – ﹤0.01% 1725
2019
Q4 		$7K Hold
300
– – ﹤0.01% 1538
2019
Q3 		$6K Hold
300
– – ﹤0.01% 1270
2019
Q2 		$6K Hold
300
– – ﹤0.01% 1665
2019
Q1 		$7K Hold
300
– – ﹤0.01% 1633
2018
Q4 		$7K Buy
+300
New +$8.25K ﹤0.01% 1529

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concourse Financial Group Securities's HRTX Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Heron Therapeutics (HRTX) in Q1 2025, closing a stake of 1,280 shares — an estimated $2.09K sold.

Concourse Financial Group Securities first reported a position in HRTX in Q4 2018 and held it in 25 quarters. The position peaked at $19K in Q4 2020. 164 funds tracked by Wall St. Rank hold HRTX as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Heron Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 1,280 Heron Therapeutics shares in Q1 2025, an estimated $2.09K.
  • Concourse Financial Group Securities first reported a position in Heron Therapeutics in Q4 2018 and held it in 25 quarters.
  • Concourse Financial Group Securities's Heron Therapeutics position peaked at $19K in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.